Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0002092017-26-000009

Options or other derivatives

  • Chief Scientific Officer acquired 248,934 shares (grant or award)
  • Chief Scientific Officer returned 248,934 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-11-13 Returned to the company · Stock Option (Right to buy) −179,619 $16.00 2035-11-04 179,619 0 D: show line 1 in the form
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-11-13 Grant or award · Stock Option (Right to buy) +179,619 $7.63 2035-11-04 179,619 179,619 D: show line 2 in the form
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-11-13 Returned to the company · Stock Option (Right to buy) −69,315 $26.77 2036-04-15 69,315 0 D: show line 3 in the form
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-11-13 Grant or award · Stock Option (Right to buy) +69,315 $7.63 2036-04-15 69,315 69,315 D: show line 4 in the form
Loading xslF345X06/primarydocument.xml…